IL6 and type 2 diabetes mellitus: In obesity, the enhanced production of IL-6 and other pro-inflammatory mediators as a result of higher BMI is associated with insulin resistance [3], [4], [5] and with a higher risk of T2D [6,7] and coronary artery disease [8].